Apnimed Inc (APMD) FinancialsAPMDApnimed Inc

Evaluating the bottom line, Apnimed Inc maintains a gross margin of 89.98%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -96.89%, while the net margin is 1043.98%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively APMD converts its operational activities into shareholder value.

In the context of the broader market, APMD competes directly with industry leaders such as GERN and VSTM. With a market capitalization of $739.36M, it holds a significant position in the sector. When comparing efficiency, APMD's gross margin of 89.98% stands against GERN's 94.94% and VSTM's 89.92%. Such benchmarking helps identify whether Apnimed Inc is trading at a premium or discount relative to its financial performance.

Apnimed's revenue surged to $84.81 million in Q1 2026, compared to $3.13 million in Q1 2025, demonstrating strong growth. The gross margin improved significantly to 97.45% in Q1 2026, reflecting efficient cost management.